J
Janice N. Cormier
Researcher at University of Texas MD Anderson Cancer Center
Publications - 222
Citations - 15284
Janice N. Cormier is an academic researcher from University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Cancer & Survival rate. The author has an hindex of 62, co-authored 222 publications receiving 13004 citations. Previous affiliations of Janice N. Cormier include University of Texas Health Science Center at Houston & University of Texas at Austin.
Papers
More filters
Journal ArticleDOI
Soft Tissue Sarcomas
TL;DR: Progress in the molecular characteristics of these tumors should in the near future translate into molecularly based therapies that can be incorporated into standard treatment strategies.
Journal ArticleDOI
Neoadjuvant immune checkpoint blockade in high-risk resectable melanoma
Rodabe N. Amaria,Sangeetha M. Reddy,Hussein Abdul-Hassan Tawbi,Michael A. Davies,Merrick I. Ross,Isabella C. Glitza,Janice N. Cormier,Carol M. Lewis,Wen-Jen Hwu,Ehab Y. Hanna,Adi Diab,Michael K. Wong,Richard E. Royal,Neil D. Gross,Randal S. Weber,Stephen Y. Lai,Richard A. Ehlers,Jorge Blando,Denái R. Milton,Scott E. Woodman,Robin Kageyama,Daniel K. Wells,Patrick Hwu,Sapna Pradyuman Patel,Anthony Lucci,Amy C. Hessel,Jeffrey E. Lee,Jeffrey E. Gershenwald,Lauren Simpson,Elizabeth M. Burton,Liberty Posada,Lauren E. Haydu,Linghua Wang,Shaojun Zhang,Alexander J. Lazar,Courtney W. Hudgens,Vancheswaran Gopalakrishnan,Alexandre Reuben,Miles C. Andrews,Christine N. Spencer,Victor G. Prieto,Padmanee Sharma,James P. Allison,Michael T. Tetzlaff,Jennifer A. Wargo +44 more
TL;DR: The feasibility of neoadjuvant immune checkpoint blockade in melanoma is described and the need for additional studies to optimize treatment regimens and to validate putative biomarkers is emphasized.
Journal ArticleDOI
Incidence, Treatment Costs, and Complications of Lymphedema After Breast Cancer Among Women of Working Age: A 2-Year Follow-Up Study
Ya Chen Tina Shih,Ying Xu,Janice N. Cormier,Sharon H. Giordano,Sheila H. Ridner,Thomas A. Buchholz,George H. Perkins,Linda S. Elting +7 more
TL;DR: Although the use of claims data may underestimate the true incidence of lymphedema, women with BCRL had a greater risk of infections and incurred higher medical costs.
Journal ArticleDOI
Meta-analysis of sentinel lymph node biopsy after preoperative chemotherapy in patients with breast cancer.
TL;DR: A meta‐analysis of studies that examined the results of SLNB after preoperative chemotherapy found that women with breast cancer are more frequently being treated with preoperative neoadjuvant chemotherapy.
Journal ArticleDOI
Lymphedema beyond breast cancer
TL;DR: A systematic review and meta‐analysis of the oncology‐related literature excluding breast cancer was performed to derive estimates of lymphedema incidence and to identify potential risk factors among various malignancies.